A carregar...

Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII

Epidermal growth factor receptor (EGFR) is frequently amplified and/or mutated in a number of human tumours and abnormal signalling from this receptor is believed to contribute to the malignant phenotype seen in these tumours. Gefitinib is a small molecule inhibitor that specifically binds and inhib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pedersen, M W, Pedersen, N, Ottesen, L H, Poulsen, H S
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2005
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361662/
https://ncbi.nlm.nih.gov/pubmed/16189524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602793
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!